Breast Cancer Clinical Trial
Official title:
Physical Activity Platform to Improve Bone Health in Cancer Survivors
Cancer treatment-induced bone loss and the subsequent risk of fractures in both men and women
impacts not just survivors' quality of life, but is also a significant burden on national
health care. Clinical studies have reported that moderate-intensity resistance exercises
prevent a decline in bone health in female cancer survivors, and that strength training may
reduce complications associated with cancer such as fatigue, muscle wasting, and bone loss.
Unfortunately, only a small percentage of women who have had cancer, engage in and adhere to
a strength training exercise routine.
The investigators have developed an internet-based application, Thrivors, that guides cancer
survivors through exercise routines with light-to-moderate strength training in the home
setting, and connects them to survivorship resources. In this Phase I proposal, the
investigators will develop and deploy an enhanced version, Thrivors+BH, that disseminates
resistance training exercises specifically impacting bone health (BH), integrated with
video-based interactive feedback and tracking of adherence to exercise routines.
The goal is to validate Thrivors+BH as a novel tool to bridge the gaps between cancer
survivorship, physical activity, value-based care and health care organizations (providers
and payers), to positively impact bone health in breast cancer survivors.
Significance: Cancer treatment-induced bone loss and the subsequent risk of fractures in both
men and women is a significant burden on national health care. The number of cancer survivors
in the United States will reach 18 million by 2022 and by 2025, the projected burden of
osteoporosis is $25.3 billion. Cancer patients treated with medications that lower hormone
levels face an increased risk of fractures. Clinical studies report that moderate- intensity
resistance exercises prevent a decline in bone health in female cancer survivors, and that
strength training may reduce complications associated with cancer such as fatigue, muscle
wasting, and bone loss. Unfortunately, only a small percentage of female cancer survivors
engage in and adhere to a strength training exercise routine. Several factors account for
this low level of engagement such as poor awareness of the benefits of exercise, lack of
motivation, and the lack of affordable and easily accessible exercise programs designed for
cancer survivors. Internet-based self-managed programs of exercises and guidance can
potentially address these problems, and can be scaled for broader dissemination.
Innovation: The Thrivors internet-based platform seeks to shift the current paradigm of poor
adherence to exercise by providing an affordable and accessible means of improving outcomes
for cancer survivors. The proposed product, Thrivors+BH, will be a first-of-its-kind offering
of clinically validated bone health exercises that can be customized to a cancer survivor's
pain and energy levels, with several novel interactive feedback features. The product will
also have supportive modules for connecting with a community of other users, mindfulness
training, nutritional advice and a repository of educational information. The Thrivors
platform is scalable, device-agnostic, and allows analysis of de-identified usage data. With
commercialization potential for healthcare providers and health insurance payers, Thrivors
provides a value-based care delivery model focused on outcomes. There are multiple important
physiologic and psychosocial secondary conditions that could be positively impacted by the
Thrivors platform. For this specific application, the investigators will focus on adherence
to bone health exercises.
Hypothesis: The investigators hypothesized that breast cancer survivors' adherence to an
exercise regimen for bone health can be improved by enhancing the interactive and
customizable features of a cloud-based, device-agnostic delivery method. To test the
hypothesis and to establish the technical feasibility of the product, the investigators
propose the following specific aims:
Specific Aim 1: Develop an enhanced participant experience platform for bone health-specific
exercises.
For Thrivors+BH, a module will be developed for participants to input pain and energy levels,
enabling real-time customization of exercise regimens. Modules of clinically validated bone
health exercises with instructional videos will be developed. Additionally, participants will
be able upload and send videos of themselves exercising for feedback and assessment. A
Thrivors Basic version that lacks customization and video content will be developed. Both
versions will contain bone health educational content, mindfulness and nutrition resources.
Milestones: Over a 2-month period, development, usability testing (assessing content,
features, input controls, navigational ease and click-through capabilities) and refinement
will be completed, to enable deployment in a randomized clinical trial.
Specific Aim 2: Measure participant adherence and engagement. The two versions of the
platform will be deployed in a 20-week, two-arm randomized controlled trial of 50 breast
cancer survivors. Adherence to exercise sessions (primary outcome) and platform usage will be
measured by platform software, while user engagement (secondary outcomes) will be assessed by
surveys. Milestones: Differences between primary and secondary outcomes for the control and
intervention groups will be evaluated. Usage statistics, motivational responses and user
feedback will be used to further refine platform features and content.
The outcomes of this study will help validate the utility of the Thrivors platform in
improving cancer survivors' adherence and engagement to exercise routines that positively
impact post-treatment recovery. In the near-term, the findings will inform the design of a
12-month Phase II study to evaluate changes in biomarkers of bone health. In the longer term,
the project aligns with the business goal to disseminate the Thrivors platform to a larger
population of male and female cancer survivors across ethnic/racial minority groups, rural
populations, and low socioeconomic status groups. The project also aligns with the mission of
the NCI to develop innovative technology and service delivery models that increase the
adoption, uptake, and sustainability of evidence-based interventions to improve public
health.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A | |
Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A |